English
Structure via PubChem · Public domain (PubChem)
fadrozole
Sign in to saveAlso known as Afema®, CGS 16949 A, CGS-16949A, FAD 286, FAD-286
Fadrozole (), sold under the brand name Afema (by Novartis), is a selective, nonsteroidal aromatase inhibitor which is or has been used in Japan for the treatment of breast cancer.
Chemical data
- Formula
- C14H13N3
- Molecular weight
- 223.27 g/mol
- IUPAC name
- 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile
- SMILES
- C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N
- InChIKey
- CLPFFLWZZBQMAO-UHFFFAOYSA-N
- XLogP
- 2.1
- Polar surface area
- 41.6 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Research
557 papers- Fadrozole and letrozole in advanced breast cancer: clinical and biochemical effects.Breast cancer research and treatment · 1998
- Fadrozole-mediated sex reversal in the embryonic chicken gonad involves a PAX2 positive undifferentiated supporting cell state.Frontiers in cell and developmental biology · 2022
- Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition?Journal of hypertension · 2006
- Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone.Endocrinology · 2008
- The effect of aromatase inhibitor, fadrozole, on sGnRHa stimulated LH secretion in goldfish (Carassius auratus) and common carp (Cyprinus carpio).Reproductive biology · 2006
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 223.110947
- Has use
- medication
Show 5 more facts
- chemical formula
- C₁₄H₁₃N₃
- canonical SMILES
- C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N
- subject has role
- aromatase inhibitors
- physically interacts with
- cytochrome P450 family 19 subfamily A member 1
- Commons category
- Fadrozole
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Fadrozole (), sold under the brand name Afema (by Novartis), is a selective, nonsteroidal aromatase inhibitor which is or has been used in Japan for the treatment of breast cancer.
==References==
Excerpted from Wikipedia’s “fadrozole” article, available under the CC BY-SA 4.0 licence.